Vanguard Group
CKPT

Vanguard Group’s Checkpoint Therapeutics CKPT Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,007,910
Closed -$8.11M 4284
2025
Q1
$8.11M Buy
2,007,910
+110,477
+6% +$446K ﹤0.01% 2962
2024
Q4
$6.07M Buy
1,897,433
+523,127
+38% +$1.67M ﹤0.01% 3188
2024
Q3
$3.08M Buy
1,374,306
+37,324
+3% +$83.6K ﹤0.01% 3430
2024
Q2
$2.87M Buy
1,336,982
+419,088
+46% +$901K ﹤0.01% 3456
2024
Q1
$1.88M Buy
917,894
+369,586
+67% +$758K ﹤0.01% 3613
2023
Q4
$1.26M Buy
548,308
+65,671
+14% +$150K ﹤0.01% 3749
2023
Q3
$820K Buy
482,637
+94,717
+24% +$161K ﹤0.01% 3904
2023
Q2
$958K Buy
387,920
+55,953
+17% +$138K ﹤0.01% 3916
2023
Q1
$747K Buy
331,967
+30,030
+10% +$67.6K ﹤0.01% 3996
2022
Q4
$1.54M Sell
301,937
-2,715,846
-90% -$13.9M ﹤0.01% 3764
2022
Q3
$3.14M Hold
3,017,783
﹤0.01% 3564
2022
Q2
$3.11M Hold
3,017,783
﹤0.01% 3610
2022
Q1
$5.34M Buy
3,017,783
+41,489
+1% +$73.4K ﹤0.01% 3498
2021
Q4
$9.26M Buy
2,976,294
+248,688
+9% +$773K ﹤0.01% 3259
2021
Q3
$9M Buy
2,727,606
+143,623
+6% +$474K ﹤0.01% 3304
2021
Q2
$7.62M Buy
2,583,983
+76,625
+3% +$226K ﹤0.01% 3355
2021
Q1
$7.87M Buy
2,507,358
+124,086
+5% +$390K ﹤0.01% 3286
2020
Q4
$6.32M Buy
2,383,272
+87,295
+4% +$231K ﹤0.01% 3244
2020
Q3
$6.15M Buy
2,295,977
+724,771
+46% +$1.94M ﹤0.01% 3041
2020
Q2
$3.11M Buy
1,571,206
+47,062
+3% +$93.2K ﹤0.01% 3300
2020
Q1
$2.3M Buy
1,524,144
+42,266
+3% +$63.8K ﹤0.01% 3267
2019
Q4
$2.55M Buy
1,481,878
+267,042
+22% +$459K ﹤0.01% 3377
2019
Q3
$3.03M Buy
1,214,836
+865
+0.1% +$2.15K ﹤0.01% 3301
2019
Q2
$3.68M Buy
1,213,971
+655,833
+118% +$1.99M ﹤0.01% 3272
2019
Q1
$1.6M Buy
558,138
+55,218
+11% +$158K ﹤0.01% 3516
2018
Q4
$916K Sell
502,920
-412,337
-45% -$751K ﹤0.01% 3590
2018
Q3
$3.28M Buy
915,257
+762,654
+500% +$2.73M ﹤0.01% 3375
2018
Q2
$455K Buy
152,603
+90,652
+146% +$270K ﹤0.01% 3836
2018
Q1
$272K Buy
+61,951
New +$272K ﹤0.01% 3911